2019 Alexander Gralnick Award Recipient
Lecture: SMI, Cardiometabolic Risks, and Accountable Care Organizations (presented at MHSC in 2019)
Dr. Henderson is a leader in the fields of schizophrenia, medical co-morbidity, and global psychiatry. He is Chief of Psychiatry at Boston Medical Center and Professor and Chair of Psychiatry at Boston University School of Medicine. He previously directed the Massachusetts General Hospital (MGH) Chester M. Pierce, M.D., Division of Global Psychiatry and the MGH Schizophrenia Clinical and Research Program. He is principal investigator and director of the BUMC-MGH Global Mental Health Clinical Research Fellowship. His research interests include ethnopsychopharmacology, treatment-resistant schizophrenia, use of psychopharmacological agents in schizophrenia treatment, and the impact of antipsychotic agents on cardiometabolic health.
| Information | ||
|---|---|---|
| File Type | jpg | |
| URL | https://www.apaf.org/getmedia/c23e710f-f0cc-4102-87b2-e4e0567e3c41/2019-David-C-Henderson.jpg | |
| Gallery | Alexander Gralnick, M.D., Award for Research in Schizophrenia | |